* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The Endogenous and Exogenous Principals
Survey
Document related concepts
Sex reassignment therapy wikipedia , lookup
Hormone replacement therapy (menopause) wikipedia , lookup
Hormone replacement therapy (male-to-female) wikipedia , lookup
Hypothalamus wikipedia , lookup
Growth hormone therapy wikipedia , lookup
Hypopituitarism wikipedia , lookup
Transcript
TSH concentrations……………...… what value should be aimed for ? The Endogenous and Exogenous Principals and effect. “The difficulty in interpreting serum TSH concentrations is to decide what value should be aimed for in patients taking thyroxine replacement. It is not sufficient to satisfy the recommendations of the American Thyroid Association or the AMA (Australia) by simply restoring both serum T4 and TSH concentrations to normal (most people would be under treated), as in our experience most patients feel well only with a dose resulting in high / normal free T4 and low / normal TSH concentration, and those patients with continuing symptoms despite ‘adequate ( blood tests say you should be well ) doses of thyroxine’, may be slightly under-replaced. Some patients (the majority) achieve a sense of wellbeing only if free T4 is slightly elevated and TSH low or undetectable (<<0.1). The evidence that this exogenous [ imposed from outside, i.e.; taking T4 and or T3 combination therapy ] form of subclinical hyperthyroidism (self induced) is harmful, is lacking in comparison to the endogenous [produced internally] variety associated with nodular goitre, and it is not unreasonable to allow these patients to take a higher dose if T3 is unequivocally normal.” Example 1: That if blood tests shown in patient ‘A’ reflect Subclinical Hyperthyroid due to Thyroid disease (endogenous). Yet, another patient, patient ‘B’ is feeling good on a progress level of Thyroxine replacement therapy (exogenous), displaying the same blood test results while the second patient, patient ‘B’, is showing no signs or symptoms of subclinical hyperthyroidism, may well be within an optimal point of treatment on a progress level of Thyroxine replacement for their Hypothyroidism. TFT QML Pathology: Thyroid Stimulating Hormone free Thyroxine (fT4) free T3 0.05 mU/L 22 pmol/L 5.9 pmol/L (0.20-4.00) (10-20) (2.8-6.8) TSH low or undetectable T4 is slightly elevated T3 is unequivocally normal Progress level - on Thyroxine replacement. 200mcg * Conventional / normal as opposed to OPTIMAL medical opinion would say that patient ‘B’, was becoming thyrotoxic / sub acute Hyperthyroidism or excess treatment on T4, yet the patient, patient ‘B’, has no Hyperthyroid’ symptoms and a general feeling of well being and hope. OPTIMAL medical opinion considers these results if congruent to other TFT results taken over time, to be conducive to patient ‘B’s personal set point, resulting in an improved quality of health. Pituitary Gland: Situated at the base of the brain (above the roof of the mouth), sends out instructions to many other glands telling them how much hormone to produce. One such hormone is TSH (Thyroid Stimulating Hormone) which signals to the thyroid gland to make thyroid hormone. The pituitary gland determines how much TSH to secrete (i.e., how much thyroid hormone to tell the thyroid gland to make) based on: How much thyroid hormone is available How much thyroid hormone the body needs How much thyroid hormone the body (actually the adrenals) can tolerate TSH (Thyroid Stimulating Hormone): Is a hormone produced by the pituitary gland and whose function is to signal the thyroid gland to make more thyroid hormone (T4). It represents the pituitary's need or desire for more thyroid hormone (T4 or T3). Thus a high TSH level is like the pituitary saying it has a ‘high need for thyroid hormone’ or the body can tolerate more thyroid energy than it is getting and it is meant to generate more thyroid hormone production. Conversely, a low TSH reflects either a low need or desire for thyroid hormone or a low tolerance for the thyroid hormone and is meant to reduce thyroid hormone production. An optimal value of TSH means the thyroid hormone levels match the body’s energy needs and/or ability to utilize the energy. Example 2: Patient B’s TSH of ‘0.05 mU/L’ (0.20 - 4.00) is the pituitary's answer to the level of Thyroxine replacement induced Exogenously. (imposed from outside - the taking of Thyroxine replacement -T4) . In all probability there is a strong case for having a different range for TSH in patients on thyroxine replacement. The hypothesis is that a doctor cannot know whether a concentration of free T4 or TSH within wide reference ranges is normal for that individual. Each individual’s thyroid function is unique and that a test result within laboratory reference ranges is not necessarily normal for that individual. Where as slight fluctuations in Thyroid Function Test (TFT) results should be taken into consideration before a titrate (adjusting) of the dose of thyroxine. As far as Thyroid function is concerned the operative word is “unique” and each patient must be treated as an individual not as part of a designated populous. (In cases of chronic adrenal fatigue, the body (actually the adrenals) can only handle a low amount of metabolic energy, so the TSH will usually be low <0.01. This is an example of the body 'down-regulating' the thyroid energy.) The successful management and treatment of Thyroid disease requires a sympathetic relationship between doctor, patient and particularly spouses. Doctors and friends who display the characteristics of empathy, acceptance of their patient and friend’s suffering, being non judgemental and attentive with a commitment to continued care and support are more likely to maximise the effects of treatment and the general well being of all. What is clearly needed now is a new prospective and adequate answers to the lingering but critical questions regarding the effects of Thyroid treatment and Thyroid failure on important end points, such as intellectual function, ischemic heart disease, and quality of life, not to mention the “Social Impact of Thyroid Conditions”. "Let's do.....All we can to do All we can. Drs Anthony D Toft & Geoffrey J Beckett, “Thyroid function tests and hypothyroidism” British Medical Journal, 8 February 2003; 326: 296-7 http://bmj.com/cgi/content/full/326/7384/295?ijkey=CFlqXBks53nhU Rick Maynard Queensland Coordinator for Thyroid Australia Thyroid Australia (Brisbane) and Brisbane Bulletin Board http://www.yourthyroidandyou.org * Conventional / normal..... Not thinking outside the box. DISCLAIMER - All materials supplied by Thyroid Australia (Brisbane) are for information purposes only and do not constitute medical advice. For medical advice please see a Doctor.